Regeneron Provides Update on Biologics License Application for Odronextamab
Go back to Regeneron Provides Update on Biologics License Application for Odronextamab| Regeneron (NASDAQ: REGN) | Delayed: 762.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $762.63 | 52 Week High | $592.36 | |||
| Open | $762.63 | 52 Week Low | $325.35 | |||
| Day High | $762.63 | P/E | 200.17 | |||
| Day Low | $762.63 | EPS | $3.81 | |||
| Volume | 323 | |||||

